Login prior to clicking the links below
KIDNEY CANCER |
|
| Welcome Address Neil Fleshner | |
| 1st and 2nd Line Therapy in Kidney Cancer: Practice Changing Trials Monty Pal |
VIEW |
| Role of Cytoreductive Nephrectomy in 2018 Ricardo Rendon |
VIEW |
BLADDER CANCER |
|
| Checkpoint Inhibitors across the Disease Spectrum - Metastatic: Scott North |
VIEW |
| Checkpoint Inhibitors across the Disease Spectrum - Non Metastatic: Wassim Kassouf |
VIEW |
| Update on Variant Histologies in Urothelial Carcinoma Theo van der Kwast |
VIEW |
| Role of Perioperative Chemotherapy in UTUC Dominick Bossé |
VIEW |
PROSTATE CANCER |
|
| Critical Appraisal of ADT in Conjunction with Post-Operative Radiation Therapy Nawaid Usmani |
VIEW |
| Current Management of M0 CRPC Kim Chi |
VIEW |
| Optimizing Therapy in Localized Prostate Cancer – ProtecT Study Freddie Hamdy |
VIEW |
TESTIS CANCER |
|
| Importance of Retroperitoneal Control in Germ Cell Tumor Joel Sheinfeld |
VIEW |